Sell ​​Dr. Reddys Laboratories Limited and buy Mahindra & Mahindra Limited

0
76

Stock Investor

Sell ​​Dr. Reddys Laboratories Limited:

Dr. Reddys Laboratories Ltd. officially announced consolidated sales of Rs. Cr 4,896.70 for the third quarter ended 09/30/2020 which is 10.85% higher than Rs’ prior quarter revenue. 4,417.50 Cr and 2.00% over last year’s sales of Rs. 4,800.80 Cr. The company reported net income after tax of Rs. 764.50 Cr in the previous quarter.

Outlook:

Dr. Reddys Laboratories Ltd: Experts suggested selling Call at current market price: Rs. 4,426.95 with a target price: Rs. 4,200; Stoploss: Rs. 4,480.

Buy Mahindra & Mahindra Limited:

Mahindra & Mahindra Limited

Mahindra & Mahindra Limited has officially announced consolidated sales of Rs. Cr 21,625.95 for the second quarter ended 09/30/2020 which is 20.09% higher than Rs’ previous quarter revenue. 23,566.75 Cr and 25% less than last year, the same quarter sales of Rs. 25,019.86 Cr. The company has reported net income after tax of Rs. 527.59 Cr in the previous quarter

Outlook:

Mahindra & Mahindra Limited: Experts recommend calling to buy at current market price: Rs. 858.1 with a target price: Rs. 880; Stoploss: Rs. 840.

Disclaimer: The perspectives and investment tips given in this section are from the expert and not the website or its management. We encourage our clients to check with certified experts before taking a position in any of the stocks mentioned.

Tags: 3M India Limited, Axis Bank Ltd., Bank of Baroda, Bombay Stock Exchange, bse, BSE Sensex, JM Financial Limited, PNB Housing Finance Limited, Can Fin Homes Ltd., Dr. Reddys Laboratories Ltd., Hindustan Zinc Ltd. Hold HDFC Limited :, national stock exchange, nifty, nse, nse nifty, navin fluorine international limited, sensex, stock market, share price, shareholders, stocks, stock market, stock market, 2021 stock exchange, share price, stocks, target price, reduce

Continue reading

Source Link

Leave a Reply